Department of Pathology and Laboratory Medicine Larner College of Medicine University of Vermont Burlington VT.
Department of Epidemiology University of Washington Seattle WA.
J Am Heart Assoc. 2020 Mar 17;9(6):e014241. doi: 10.1161/JAHA.119.014241. Epub 2020 Mar 11.
Background Soluble CD14 (sCD14), a circulating pattern recognition receptor, has been suggested as a cardiovascular disease risk factor. Prospective studies evaluating sCD14 with incident cardiovascular disease events are limited, particularly among racially diverse populations. Methods and Results Between 2003 and 2007, the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study recruited 30 239 black and white participants across the United States. In a nested case-cohort study, sCD14 was measured in baseline serum from 548 cases of incident ischemic stroke, 612 cases of incident coronary heart disease (CHD), and a cohort random sample (n=1039). Cox models estimated hazards ratios (HR) of incident ischemic stroke or CHD per 1 SD higher sCD14, adjusting for cardiovascular disease risk factors. There was a differential association of sCD14 with ischemic stroke and CHD risk by race. Among blacks, the adjusted HR of stroke per SD increment of sCD14 was 1.42 (95% CI: 1.12, 1.80), with no association among whites (HR 1.02 [95% CI: 0.82, 1.27]). Higher sCD14 was associated with increased CHD risk in blacks but not whites, and relationships between sCD14 and CHD were stronger at younger ages. Adjusted for risk factors, the HR of CHD per SD higher sCD14 among blacks at age 45 years was 2.30 (95% CI: 1.45, 3.65) compared with 1.56 (95% CI: 0.94, 2.57) among whites. At age 65 years, the CHD HR was 1.51 (95% CI: 1.20, 1.91) among blacks and 1.02 (95% CI: 0.80, 1.31) among whites. Conclusions sCD14 may be a race-specific stroke and CHD risk marker.
背景 可溶性 CD14(sCD14)是一种循环模式识别受体,被认为是心血管疾病的风险因素。评估 sCD14 与心血管疾病事件的前瞻性研究有限,特别是在不同种族的人群中。
方法和结果 在 2003 年至 2007 年期间,REGARDS(地理和种族差异中风原因)研究在美国各地招募了 30239 名黑人和白人参与者。在一项巢式病例对照研究中,548 例新发缺血性卒中、612 例新发冠心病(CHD)和队列随机样本(n=1039)的基线血清中检测了 sCD14。Cox 模型估计了 sCD14 每增加 1 个标准差时发生缺血性卒中或 CHD 的风险比(HR),并调整了心血管疾病危险因素。sCD14 与缺血性卒中和 CHD 风险的相关性在不同种族之间存在差异。在黑人中,sCD14 每增加 1 个标准差,卒中的调整后 HR 为 1.42(95%CI:1.12,1.80),而白人中无相关性(HR 1.02[95%CI:0.82,1.27])。黑人中 sCD14 水平升高与 CHD 风险增加相关,但白人中无相关性,且 sCD14 与 CHD 之间的关系在较年轻时更强。调整危险因素后,黑人 45 岁时 sCD14 每增加 1 个标准差,CHD 的 HR 为 2.30(95%CI:1.45,3.65),而白人则为 1.56(95%CI:0.94,2.57)。黑人 65 岁时,CHD 的 HR 为 1.51(95%CI:1.20,1.91),而白人则为 1.02(95%CI:0.80,1.31)。
结论 sCD14 可能是一种种族特异性的卒中及 CHD 风险标志物。
J Am Heart Assoc. 2020-3-17
J Am Heart Assoc. 2015-7-1
J Diabetes Metab Disord. 2024-12-16
J Racial Ethn Health Disparities. 2024-10-28
Arterioscler Thromb Vasc Biol. 2024-10
Res Pract Thromb Haemost. 2021-12-7
Arterioscler Thromb Vasc Biol. 2021-6
Int J Mol Sci. 2020-11-3
J Am Heart Assoc. 2018-7-13